U.S. Logistics Stock News

NasdaqGS:REG
NasdaqGS:REGRetail REITs

Regency Centers Note Sale Sparks Fresh Questions On Debt And Valuation

Regency Centers completed a public offering of $450 million in senior unsecured notes due 2033. The issuance is intended to support balance sheet optimization and ongoing development activities. The company trades on the NasdaqGS under the ticker NasdaqGS:REG, with a current share price of $79.0. For investors watching NasdaqGS:REG, this $450 million notes offering is a fresh data point on how Regency Centers is managing its capital structure. The stock is at $79.0, with returns of 2.8%...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

A Look At LPL Financial Holdings (LPLA) Valuation After Recent Share Price Weakness

LPL Financial Holdings (LPLA) has drawn attention after a period of weaker share performance, with returns over the past month, past 3 months, and year all in negative territory, even though multi year total returns remain positive. See our latest analysis for LPL Financial Holdings. The recent 1 month share price return of a 17.59% decline and year to date share price return of a 16.94% decline point to fading near term momentum, even though the 5 year total shareholder return of 129.88%...
NYSE:OC
NYSE:OCBuilding

Owens Corning Losses Spur Questions On Earnings Recovery And Valuation

Owens Corning (NYSE:OC) reported a net loss for the fourth quarter, reversing net income from the same period a year earlier. The company also posted a full year net loss, a material deterioration compared with the prior year's profitability. Recent results came in below earnings expectations, highlighting weaker than anticipated financial performance. For investors watching NYSE:OC, this shift to losses comes with the stock recently closing at $122.07. Shares are down 8.0% over the past...
NYSE:BCC
NYSE:BCCTrade Distributors

Is Boise Cascade (BCC) Fairly Priced After Housing Demand Headlines And Recent Share Pullback

If you are wondering whether Boise Cascade's share price still reflects its real worth, looking at how the market has treated the stock over different time frames is a useful starting point. The stock last closed at US$82.74, with returns of 0.7% over 7 days, 3.0% over 30 days, 11.6% year to date, but a 19.3% decline over 1 year and longer term returns of 36.4% over 3 years and 107.2% over 5 years. Recent headlines around Boise Cascade have focused on its position as a major supplier of...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Intellia Trial Milestones Refocus Attention On Gene Editing Risk And Reward

FDA lifts clinical hold on Intellia Therapeutics' MAGNITUDE-2 ATTR amyloidosis trial, allowing global enrollment to resume with updated safety protocols. Intellia completes phase 3 enrollment ahead of schedule in the HAELO trial for lonvo-z, a one time gene editing therapy for hereditary angioedema. These steps advance Intellia Therapeutics' late stage pipeline and move its gene editing candidates closer to potential approval and commercialization. For investors watching Intellia...
NasdaqGS:LINE
NasdaqGS:LINEIndustrial REITs

Is It Time To Reassess Lineage (LINE) After Recent Real Estate Sector Rethink?

If you are trying to work out whether Lineage at around US$40.52 is a bargain or just fairly priced, you are in the right place. The stock has recently posted returns of 5.8% over 7 days, 12.6% over 30 days and 14.4% year to date, although the 1 year return sits at a 29.3% decline. Recent attention on Lineage has focused on its position in the US real estate space and how investors are reassessing companies in the sector, which helps frame these recent price moves. Coverage has regularly...
NYSE:THR
NYSE:THRElectrical

Thermon Buyout By CECO Sparks Valuation Questions And Fairness Reviews

Thermon Group Holdings (NYSE:THR) has entered into a definitive agreement to be acquired by CECO Environmental Corp. in a cash and stock deal. The transaction proposes different forms of consideration for existing Thermon shareholders, subject to customary approvals. Law firms have launched investigations into whether the terms of the acquisition are fair to Thermon shareholders. Thermon shares most recently closed at $50.78, with the stock showing returns of 34.9% year to date and 72.1%...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Is It Time To Reassess Warby Parker (WRBY) After Its Google Partnership And Recent Rally?

Wondering if Warby Parker at around US$25.01 is priced for its brand story or for its actual fundamentals? This article breaks down what the current share price may be implying about value. The stock has had a mixed run, with a 5.5% return over the past week, a 2.0% decline over the last 30 days, a 10.6% return year to date and a 1.1% return over the past year, while the 3 year return sits at 100.4%. Recent headlines around Warby Parker have focused on its position in the US eyewear retail...
NYSE:H
NYSE:HHospitality

Hyatt Leadership Shift Raises Governance And Reputational Questions For Investors

Hyatt Hotels (NYSE:H) announced the retirement of Executive Chairman Thomas J. Pritzker after more than two decades in the role. The move comes alongside public mention of Pritzker's past association with Jeffrey Epstein and Ghislaine Maxwell. Hyatt has appointed current CEO Mark S. Hoplamazian as the new Chairman, concentrating leadership in a single figure. The transition highlights both succession planning and governance considerations for the company. For you as an investor, the key...
NYSE:WTRG
NYSE:WTRGWater Utilities

Essential Utilities Merger With American Water Puts Valuation And Risks In Focus

Essential Utilities (NYSE:WTRG) has agreed to an all stock merger with American Water Works Company. The transaction is expected to close by the end of the first quarter of 2027, following recent shareholder approval. The company is also planning substantial investments in water and natural gas systems and continuing expansion through acquisitions. Essential Utilities focuses on regulated water and natural gas services, a segment that often attracts investors looking for stability and...
NYSE:PNC
NYSE:PNCBanks

A Look At PNC Financial Services Group (PNC) Valuation After Recent Share Price Pullback

Event overview and recent share performance PNC Financial Services Group (PNC) has attracted attention after the stock fell about 4.7% in the latest session and is down roughly 8.9% over the past week. Despite these short term moves, PNC shares show a gain of around 10.4% over the past 3 months and a total return of about 14.7% over the past year, drawing interest from investors tracking regional banks. See our latest analysis for PNC Financial Services Group. With the share price at $212.35,...
NYSE:ASPN
NYSE:ASPNChemicals

A Look At Aspen Aerogels (ASPN) Valuation After Steep Losses And Manufacturing Impairment

Why Aspen Aerogels is back in focus Aspen Aerogels (ASPN) is back on investors’ radar after reporting a sharp year over year revenue decline, a large full year net loss, a sizeable impairment charge, and guidance indicating continued losses. See our latest analysis for Aspen Aerogels. The stock’s recent swings reflect this reset in expectations, with a 7 day share price return showing a 13.57% decline and a 1 year total shareholder return indicating a 59% loss, highlighting how pressure has...
NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Xcel Energy And Google Data Center Put Growth Plans And Valuation In Focus

Xcel Energy (NasdaqGS:XEL) announced a new partnership with Google to support a major data center project. The development includes what is described as the world's largest iron air battery installation to support clean energy use and grid reliability. Xcel Energy plans to structure the project so that existing customers are not impacted by the data center's large power needs. The company also appointed Rob Cain as Chief Technology Officer, with responsibility for driving technology and...
NYSE:AS
NYSE:ASLuxury

Is Amer Sports (AS) Pricing In Too Much Optimism After Recent Share Price Swings?

If you are wondering whether Amer Sports at around US$37.98 is offering good value or not, you are not alone. This article is here to unpack that question clearly. The stock has had a mixed run, with a 9.5% decline over the last 7 days, a 3.7% gain over the past month, and a 27.1% return over the last year, which can change how investors think about both upside and risk. Recent news coverage has focused on Amer Sports as a consumer durables name that investors are watching for how it...
NYSE:PSN
NYSE:PSNProfessional Services

Is Parsons (PSN) Still Attractive At US$66 After Recent Government Contract Attention?

If you are wondering whether Parsons at around US$66 still offers value, or if the easy gains are already behind it, this article is for you. Parsons' share price sits at about US$66 after a 0.7% return over the last week, a 1 month return showing an 8.0% decline, and longer term returns of 6.1% year to date, 13.4% over 1 year, 45.3% over 3 years, and 80.7% over 5 years. These moves have put Parsons on the radar of investors who are watching how its government and infrastructure work is...
NYSE:FLUT
NYSE:FLUTHospitality

Flutter Entertainment Reassesses Growth As FanDuel Predicts Faces Regulatory Tests

Flutter Entertainment, NYSE:FLUT, missed recent revenue expectations and issued guidance for 2026 that some investors view as cautious. The company has launched FanDuel Predicts, expanding into prediction markets at a time when regulators are paying closer attention to the sector. These moves come as competition in online wagering and prediction products intensifies, raising questions about Flutter Entertainment's next phase of growth. For shareholders, the backdrop is already challenging...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Why MannKind (MNKD) Is Down 40.8% After Earnings Miss And New Tyvaso DPI Rival Appears

MannKind Corporation reported past fourth-quarter 2025 results with revenue rising to US$111.96 million, but swinging from prior net income to a US$15.95 million net loss, while full-year 2025 revenue increased to US$348.97 million alongside a lower net income of US$5.86 million. A key risk emerged as partner United Therapeutics recently unveiled a competing soft-mist treprostinil inhaler that could challenge MannKind’s Tyvaso DPI royalty stream, increasing uncertainty around the company’s...
NYSE:DEA
NYSE:DEAOffice REITs

A Look At Easterly Government Properties (DEA) Valuation As Recent Momentum Meets Mixed Long Term Returns

Easterly Government Properties (DEA) focuses on Class A properties leased to U.S. government agencies, and its stock has seen mixed returns, with a monthly gain alongside a negative 1-year total return. See our latest analysis for Easterly Government Properties. At a share price of $23.28, Easterly Government Properties has a 30 day share price return of 3.28% and a year to date share price return of 9.24%. The 1 year total shareholder return of 9.89% and 5 year total shareholder return of...
NYSE:SDRL
NYSE:SDRLEnergy Services

Seadrill’s Record Safety And Contract Wins Set Stage For 2026 Earnings

Seadrill (NYSE:SDRL) reported record operational and safety performance, marking its best safety results to date. The company secured several long term contracts, including a key award in Malaysia in the deepwater segment. Management highlighted strong execution on complex offshore projects alongside ongoing market challenges such as high reactivation costs and regional softness. At a share price of $43.88, Seadrill is drawing attention as it pairs operational execution with what the...
NYSE:AHR
NYSE:AHRHealth Care REITs

Is It Too Late To Consider American Healthcare REIT (AHR) After An 80% One-Year Rally?

If you are wondering whether American Healthcare REIT is attractively priced at around US$52.24, you are not alone. Many investors are asking if the recent run reflects its true value or if there is still room on the table. The stock has returned 0.6% over the last 7 days, 10.6% over the past month, and 80.1% over the past year, which naturally raises questions about how risk and reward now stack up. Recent coverage has focused on American Healthcare REIT as a healthcare focused real estate...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

Phathom Pharmaceuticals (PHAT) Is Up 10.0% After Guiding to 2026 Operating Profitability and Raising Capital

In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a much smaller net loss of US$21.15 million for the quarter and US$221.25 million for the year, alongside guidance for 2026 that includes expected operating profitability (excluding stock-based compensation) beginning in the third quarter. The company also strengthened its financial position through a US$130 million equity raise, reworked term loans, and ongoing uptake of its VOQUEZNA...
NYSE:ABR
NYSE:ABRMortgage REITs

Arbor Realty Trust (ABR) Dividend Coverage Concerns Reinforce Bearish Narratives

Arbor Realty Trust (ABR) just closed out FY 2025 with Q4 revenue of US$81.3 million and basic EPS of US$0.07, capping a year where trailing twelve month revenue came in at US$467.7 million and EPS at US$0.56. Over recent quarters the company has seen quarterly revenue range from US$111.1 million to US$140.7 million with EPS between US$0.12 and US$0.20, while trailing twelve month revenue has moved between US$467.7 million and US$650.4 million and EPS between US$0.56 and US$1.35. This sets the...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

Is It Time To Reassess NetScout Systems (NTCT) After Its 30% One-Year Share Price Gain?

If you are wondering whether NetScout Systems is priced attractively right now, the recent share performance gives you a useful starting point but not the full story on value. The stock closed at US$29.21, with a 1.6% decline over the last 7 days, a 4.1% gain over 30 days, an 8.8% gain year to date, and a 29.9% return over the past year, while the 3 year and 5 year returns sit at 3.2% and 6.3% respectively. These moves come against a backdrop of ongoing interest in networking and...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Is It Too Late To Consider ACM Research (ACMR) After Its 115% One Year Surge?

If you are wondering whether ACM Research at around US$55.68 is still good value after its big run, you are not alone. This article is designed to help you make sense of what that price might imply. The stock has been volatile recently, with a 16.4% decline over the last 7 days, a 1.8% gain over 30 days, and returns of 24.1% year to date and 114.6% over the past year, while the 3 year return is very large and the 5 year return is 89.6%. Recent attention on semiconductor related names, as...